Discordance of apolipoprotein B with low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol and coronary atherosclerosis

被引:19
|
作者
Su, Xin [1 ,2 ]
Cai, Xueli [3 ]
Pan, Yuesong [4 ,5 ]
Sun, Jingping [3 ]
Jing, Jing [4 ,5 ]
Wang, Mengxing [4 ,5 ]
Meng, Xia [4 ,5 ]
Wang, Yongjun [4 ,5 ]
Wei, Tiemin [6 ]
He, Yan [1 ,2 ]
机构
[1] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[2] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China
[3] Zhejiang Univ, Lishui Hosp, Dept Neurol, Sch Med, Lishui, Peoples R China
[4] Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing, Peoples R China
[5] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[6] Zhejiang Univ, Lishui Hosp, Dept Cardiol, Sch Med, Lishui, Peoples R China
基金
中国国家自然科学基金;
关键词
Apolipoproteins; Coronary atherosclerosis plaques; Discordance analysis; Lipoproteins; PROGNOSTIC VALUE; LDL-CHOLESTEROL; ARTERY CALCIFICATION; COMPUTED-TOMOGRAPHY; RISK; ANGIOGRAPHY; DISEASE; EVENTS; DYSLIPIDEMIA; MANAGEMENT;
D O I
10.1093/eurjpc/zwac223
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims High level of apolipoprotein B (Apo B) is associated with incident subclinical atherosclerosis. The present study evaluated the associations between discordant Apo B with low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and coronary atherosclerotic burden. Methods and results This study enrolled 3043 participants aged 50-75 years from the PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE) study that was conducted in the community in Lishui City, China. Discordant Apo B with LDL-C and non-HDL-C were defined by residuals and medians. Coronary atherosclerotic burden was evaluated by segment involvement score (SIS) and segment stenosis score (SSS) which were determined by computed tomography angiography. We performed discordance analyses examining associations of discordant Apo B with LDL-C or non-HDL-C with the coronary atherosclerotic burden. The mean age of participants was 61.2 +/- 6.7 years, 53.6% were females. Participants with discordant high Apo B relative to non-HDL-C were at higher odds of plaques [odds ratio (OR), 1.30; 95% confidence interval (CI), 1.08-1.57], SIS [common odds ratio (cOR), 1.35; 95% CI, 1.14-1.60], and SSS (cOR, 1.40; 95% CI, 1.18-1.67) compared with concordant group. However, discordantly low Apo B with non-HDL-C was associated with decreased odds of the coronary atherosclerotic plaques and its burden. Similar results were shown for discordant analyses for Apo B with LDL-C. Conclusion Discordantly high Apo B with LDL-C and non-HDL-C were associated with an increased odds of the coronary atherosclerotic plaques and its burden. These findings highlighted the importance of Apo B for primary prevention of coronary atherosclerosis.
引用
收藏
页码:2349 / 2358
页数:10
相关论文
共 50 条
  • [21] Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese
    Gu, Xiaoying
    Yang, Xueli
    Li, Ying
    Cao, Jie
    Li, Jianxin
    Liu, Xiaoqing
    Chen, Jichun
    Shen, Chong
    Yu, Ling
    Huang, Jianfeng
    Gu, Dongfeng
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (07): : 1063 - 1070
  • [22] Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol Are Better Risk Markers for Coronary Artery Disease than Low-Density Lipoprotein Cholesterol in Hypertriglyceridemic Metabolic Syndrome Patients
    Boumaiza, Imen
    Omezzine, Asma
    Rejeb, Jihene
    Rebhi, Lamia
    Kalboussi, Nesrine
    Ben Rejeb, Nabila
    Nabli, Naoufel
    Ben Abdelaziz, Ahmed
    Boughazala, Essia
    Bouslama, Ali
    METABOLIC SYNDROME AND RELATED DISORDERS, 2010, 8 (06) : 515 - 522
  • [23] Fasting non-high-density lipoprotein cholesterol and low-density lipoprotein particle size Reply
    Li, Chaoyang
    Ford, Earl S.
    Gidding, Samuel S.
    JOURNAL OF PEDIATRICS, 2012, 160 (03): : 532 - 532
  • [24] Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper
    Colivicchi, Furio
    Di Fusco, Stefania Angela
    Arca, Marcello
    Leggio, Massimo
    Caldarola, Pasquale
    Murrone, Adriano
    Valente, Serafina
    Urbinati, Stefano
    Roncon, Loris
    Amodeo, Vincenzo
    Aspromonte, Nadia
    Cipriani, Manlio
    Domenicucci, Stefano
    Francese, Giuseppina Maura
    Imazio, Massimo
    di Uccio, Fortunato Scotto
    Di Lenarda, Andrea
    Gulizia, Michele Massimo
    Gabrielli, Domenico
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (08) : 609 - 617
  • [25] DISCORDANCE OF LOW DENSITY LIPOPROTEIN CHOLESTEROL AND NON-HIGH DENSITY LIPOPROTEIN CHOLESTEROL AND CORONARY ARTERY DISEASE SEVERITY
    Kurmus, O.
    Aslan, T.
    Eren, M.
    Ekici, B.
    Fahri, A. Erkan
    ATHEROSCLEROSIS, 2019, 287 : E179 - E180
  • [26] Weighing in before the fight - Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy
    Denke, MA
    CIRCULATION, 2005, 112 (22) : 3368 - 3370
  • [27] Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: Effect of 5 hydroxymethylglutaryl coenzyme a reductase inhibitors on non-high-density lipoprotein cholesterol levels
    Ballantyne, CM
    Andrews, TC
    Hsia, JA
    Kramer, JH
    Shear, C
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03): : 265 - 269
  • [28] Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
    Pischon, T
    Girman, CJ
    Sacks, FM
    Rifai, N
    Stampfer, MJ
    Rimm, EB
    CIRCULATION, 2005, 112 (22) : 3375 - 3383
  • [29] Apolipoprotein B versus non-high-density lipoprotein cholesterol - And the winner is...
    Sniderman, AD
    CIRCULATION, 2005, 112 (22) : 3366 - 3367
  • [30] To B or Not to B: Is Non-High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B?
    Lavie, Carl J.
    Milani, Richard V.
    O'Keefe, James H.
    MAYO CLINIC PROCEEDINGS, 2010, 85 (05) : 446 - 450